Showing results (11-20 of 70) with videos related to
Sort By:
Pageof 7
Journal of Clinical Gastroenterology|November 29, 2012
Safety and tolerability of low-dose naltrexone therapy in children with moderate to severe Crohn's disease: a pilot studyJill P Smith, Douglas Field, Sandra I Bingaman, et al.Journal of General Internal Medicine|June 24, 2004
Amantadine therapy for chronic hepatitis CJill P Smith, Thomas R Riley, Attila Devenyi, et al.Digestive Diseases and Sciences|October 11, 2019
Cholecystokinin Receptor Antagonist Therapy Decreases Inflammation and Fibrosis in Chronic PancreatitisSandeep Nadella, Victor Ciofoaia, Hong Cao, et al.The American Journal of Gastroenterology|January 16, 2007
Low-dose naltrexone therapy improves active Crohn's diseaseJill P Smith, Heather Stock, Sandra Bingaman, et al.Pharmaceutics|May 25, 2024
The Role of a Cholecystokinin Receptor Antagonist in the Management of Chronic Pancreatitis: A Phase 1 TrialVictor Ciofoaia, Wenqiang Chen, Bakain W Tarek, et al.Frontiers in Oncology|December 20, 2021
Gastrin Vaccine Alone and in Combination With an Immune Checkpoint Antibody Inhibits Growth and Metastases of Gastric CancerJill P Smith, Hong Cao, Wenqiang Chen, et al.Cancers|September 27, 2025
Mechanistic Insights into Proglumide's Role in Immune Cell Efficacy and Response to Immune Checkpoint Inhibitor Therapy in Hepatocellular CarcinomaPriyanka S Doneparthi, Hong Cao, Wenqiang Chen, et al.Clinical and Translational Gastroenterology|April 19, 2013
Therapeutic effect of vitamin d supplementation in a pilot study of Crohn's patientsLinlin Yang, Veronika Weaver, Jill P Smith, et al.American Journal of Physiology. Gastrointestinal and Liver Physiology|March 24, 2012
Downregulation of the CCK-B receptor in pancreatic cancer cells blocks proliferation and promotes apoptosisKristin K Fino, Gail L Matters, Christopher O McGovern, et al.Cancers|June 22, 2023
Cholecystokinin Receptor Antagonist Induces Pancreatic Stellate Cell Plasticity Rendering the Tumor Microenvironment Less OncogenicGurbani Jolly, Tetyana Duka, Narayan Shivapurkar, et al.Pageof 7